Long-term follow-up of hepatitis B surface antibody levels in subjects receiving universal hepatitis B vaccination in infancy in an area of hyperendemicity: Correlation between radioimmunoassay and enzyme immunoassay

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 12, 2005, Pages 1442-1447

  Wang, Ching Wen ^a   Wang, Li Chieh ^a   Chang, Mei Hwei ^a   Ni, Yen Hsuan ^a   Chen, Huey Ling ^a   Hsu, Hong Yuan ^a   Chen, Ding Shin ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENGERIX; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RICOMBIVAX;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOGENICITY; LONG TERM CARE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SCHOOL CHILD; VACCINATION;

ADOLESCENT; CHILD; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOENZYME TECHNIQUES; RADIOIMMUNOASSAY;

EID: 29144502416     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.12.1442-1447.2005     Document Type: Article

References (30)

1. Beasley, R. P., L. Y. Hwang, C. C. Lin, M. L. Leu, C. E. Stevens, W. Szmuness, et al. 1982. Incidence of hepatitis B virus infections in preschool children in Taiwan. J. Infect. Dis. 146:198-204.
2. Benhamou, E., A.-M. Courouce, A. Laplanche, P. Jungers, J. F. Tron, and J. Crosnier. 1986. Long-term results of hepatitis B vaccination in patients on dialysis. N. Engl. J. Med. 314:1710-1711.
3. Bryan, J. P., M. H. Sjogren, P. Macarthy, B. Cox, T.-C. Kao, and P. L. Perine. 1991. Dosing schedule for recombinant hepatitis B vaccine. J. Infect. Dis. 163:1384-1385.
4. Chang, M. H., C. J. Chen, M. S. Lai, H. M. Hsu, T. C. Wu, M. S. Kong, et al. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:1855-1859.
5. Couroucé, A. M., P. Jungers, E. Benhamou, A. Laplanche, and J. Crosnier. 1984. Hepatitis B vaccine in dialysis patients. N. Engl. J. Med. 311:1515-1516.
6. Coursaget, P., D. Leboulleux, M. Soumare, et al. 1994. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J. Hepatol. 21:250-254.
7. Coursaget, P., B. Yvonnet, W. Gilks, C. C. Wang, N. E. Day, J. P. Chiron, et al. 1991. Scheduling of revaccination against hepatitis B virus. Lancet 337: 1180-1183.
8. Crosnier, J., P. Jungers, A.-M. Courouce, et al. 1981. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. I. Medical staff. Lancet i:455-459.
9. Dentico, P., R. Buongiorno, A. Zavoianni, A. Volpe, G. Pastore, and O. Schiraldi. 1990. Immunogenicity of HEVAC-B Pasteur vaccine in infants: comparison of 2 and 5 meg. p. 325-332. In P. Coursaget and M. J. Tong (ed.). Progress in hepatitis B immunization. Editions John Libbey Eurotext, Montrouge. France.
10. Gesemann, M., and N. Scheiermann. 1989. Timing of booster doses of hepatitis B vaccine. Lancet ii:1274.
11. Geseman, M., and N. Scheiermann. 1995. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 13:443-447.
12. Goilav, C., H. Prinsen, and P. Piot. 1990. Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months. Vaccine 8:S50-S52.
13. Goudeau, A., F. Dubois, and P. Asou. 1990. Long-term persistence of anti-HBs after hepatitis B immunization in adults, p. 123-137. In P. Coursaget and M. J. Tong (ed.), Progress in hepatitis B immunization. Editions John Libbey Eurotext, Montrouge, France.
14. Grob, P. J., A. Dufek, and H. I. Joller-Jemelka. 1985. Hepatitis B immunisation-when is a booster injection necessary? Schweiz. Med. Wochenschr. 115:394-402.
15. Huang, L. M., B. L. Chiang, C. Y. Lee, P. I. Lee, W. K. Chi, and M. H. Chang. 1999. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 29:954-959.
16. Jilg, W., M. Schmidt, F. Deinhardt, and R. Zachoval. 1984. Hepatitis B vaccination: how long does protection last? Lancet ii:458.
17. Laplanche, A., A.-M. Courouce, E. Benhamou, and P. Jungers. 1987. Timing of hepatitis B revaccination in healthy adults. Lancet i: 1206-1207.
18. Lin, Y. C., M. H. Chang, Y. H. Ni, H. Y. Hsu, and D. S. Chen. 2003. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J. Infect. Dis. 187:134-138.
19. Mintai, Z., L. Kezhou, D. Lieming, and R. A. Smego, Jr. 1993. Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents. Clin. Infect. Dis. 16:165-167.
20. Ni, Y. H., M. H. Chang, L. M. Huang, H. L. Chen, H. Y. Hsu, T. Y. Chiu, et al. 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann. Intern. Med. 135:796-800.
21. 13a. Oon, C. J., K. T. Goh, K. L. Tan, S. H. Chan, and G. K. Lim. 1990. Experience of hepatitis B prevention and control programme in Singapore, p. 475-489. In P. Coursaget and M. J. Tong (ed.), Progress in hepatitis B immunization. Editions John Libbey Eurotext, Montrouge, France.
22. Shih, H. H., M. H. Chang, H. Y. Hsu, P. I. Lee, Ni, Y. H., and D. S. Chen. 1999. Long-term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Pediatr. Infect. Dis. J. 18:427-432.
23. Stevens, C. F., R. P. Beasley, J. J. Tsui, and W. C. Lee. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:771-774.
24. Tsen, Y. J., M. H. Chang, H. Y. Hsu, C. Y. Lee, J. L. Sung, and D. S. Chen. 1991. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J. Med Virol. 34:96-99.
25. Wainwright, R. B., L. R. Bulkow, A. J. Parkinson, C. Zanis, and B. J. McMahon. 1997. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J. Infect. Dis. 175:674-677.
26. West, D. J., and G. B. Calandra. 1996. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14:1019-1027.
27. West, D. J., B. Watson, J. Lichtman, T. M. Hesley, and K. Hedberg. 1994 Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr. Infect. Dis. J. 13:745-747.
28. Yvonnet, B., P. Coursaget, J. Chotard, et al. 1987. Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination. J. Med. Virol. 22:315-321.
29. Zachoval, R., W. Jilg, B. Lorbeer, M. Schmidt, and F. Deinhardt. 1984. Passive/active immunisation against hepatitis B. J. Infect. Dis. 150:112-117.
30. Zanetti, A. R., E. Tanzi, L. Romano, D. Mari, M. Colombo, and P. M. Mannucci. 1990. Anti-pre-S2 and anti-HBs responses in hemophiliacs vaccinated with a plasma-derived vaccine. A four year follow-up study, p. 79-86. In P. Coursaget and M. J. Tong (ed.) Progress in hepatitis B immunization. Editions John Libbey Eurotext, Montrouge, France.